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The human immunodeficiency virus type 1 (HIV-1) envelope comprises a surface gp120 and a transmem-
brane gp41. The cytoplasmic domain of gp41 contains cysteine residues (C764 and C837) which are targets for
palmitoylation and were reported to be required for envelope association with lipid rafts and assembly on
budding virions (I. Rousso, M. B. Mixon, B. K. Chen, and P. S. Kim, Proc. Natl. Acad. Sci. USA 97:13523–
13525, 2000). Several infectious HIV-1 clones contain envelopes that have no gp41 cytoplasmic cysteines. Since
no other gp41 amino acid is a target for palmitoylation, these clones imply that palmitoylation is not essential
for envelope trafficking and assembly. Here, we show that HIV-1 envelope mutants that lack gp41 cytoplasmic
cysteines are excluded from light lipid rafts. Envelopes that contained residues with bulky hydrophobic side
chains instead of cysteines retained their association with heavy rafts and were nearly fully functional for
incorporation into virions and infectivity. Substitution of cysteines with alanines or serines eliminated raft
association and more severely reduced envelope incorporation onto virions and their infectivity. Nevertheless,
the A764/A837 mutant envelope retained nearly 40% infectivity compared to the wild type, even though this
envelope was excluded from lipid rafts. Our results demonstrate that gp41 cytoplasmic cysteines that are
targets for palmitoylation and are required for envelope trafficking to classical lipid rafts are not essential for
HIV-1 replication.
The covalent attachment of fatty acid groups, e.g., myristate
and palmitate, to proteins plays an important role in their
structure and function. Such fatty acid groups usually facilitate
the interaction of proteins with lipid membranes. The cytoplas-
mic regions of diverse viral envelope glycoproteins contain
cysteines that are targets for palmitoylation. Such viruses in-
clude orthomyxoviruses (influenza virus) (28), alphaviruses
(Sindbis virus) (9), retroviruses (Rous sarcoma virus) (17), and
lentiviruses (human immunodeficiency virus [HIV]) (21, 26).
Although the exact function of palmitoylation is not known, it
has been proposed to target viral glycoproteins into the lipid
rafts (20) of the membranes for incorporation onto newly bud-
ding virions (21). However, Dolganiuc et al. recently reported
that the addition of palmitate to the cytoplasmic domain of
Newcastle disease virus was not required for lipid raft associ-
ation (7).
Lipid rafts (also known as detergent-resistant glycosphingo-
lipid glycosylphosphatidylinositol [GPI]-enriched membranes
or detergent-resistant membrane fragments [DRMs]) are dis-
crete microdomains in cell membranes that are enriched in
specific types of lipids and proteins and insoluble in cold non-
ionic detergents (3, 14, 20). Lipid rafts are rich in sphingolipids
and cholesterol and contain GPI-linked as well as palmitoy-
lated proteins (14, 20, 22). This combination of lipids may
support the efficient budding of newly synthesized virions (18).
Purified HIV particles thus contain high concentrations of
cholesterol, sphingomyelin, and GPI-anchored glycoproteins,
consistent with lipid rafts as the sites of budding (2). Recently,
the definition of lipid rafts has been refined to distinguish light
and heavy lipid rafts (16). In sucrose gradients, classical rafts
are light and are present in fractions with densities between
1.09 and 1.13 g/ml. Nebl et al. described a heavier raft that was
present in fractions with densities between 1.16 and 1.2 g/ml.
These heavy rafts were termed DRM-H to distinguish them
from the lighter DRM-L rafts (16).
HIV envelopes usually contain two cysteines (C764 and
C837) in the cytoplasmic domain (Fig. 1A) that have been
shown to be palmitoylated (26). The gp41 cytoplasmic domain
is a complex region of about 150 amino acids. Several gp41
regions form -helices that interact with lipid bilayers (4).
Three such -helices were described as lentivirus lytic peptides
(LLPs) (Fig. 1). C764 is located immediately upstream of
LLP-2 and may therefore help anchor this region to the cell
membrane. C837 is located in LLP-1. The precise functions of
the gp41 cytoplasmic domain are not clear. This region has
been shown to interact with several cellular proteins (8, 11, 24,
27) and contains determinants for binding to the matrix do-
main of the p55gag precursor (10, 15).
Mutations that replaced both gp41 cytoplasmic cysteines
with serines were shown to completely eliminate palmitoy-
lation (26). These substitutions also resulted in decreased as-
sociation of envelopes with lipid rafts, decreased incorporation
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onto virions, and a severe reduction in infectivity (21). Never-
theless, 5% of envelope sequences in the HIV sequence data-
base (http://hiv-web.lanl.gov) do not contain cysteines at posi-
tions 764 and 837. A widely used molecular clone of HIV type
1 (HIV-1), pJRCSF, contains no cysteines in the gp41 cyto-
plasmic domain yet is fully replication competent and fusi-
genic, thus implying that palmitoylation of gp41 is not essential
for HIV-1 replication. Here, we have directly tested whether
gp41 cytoplasmic cysteines can be replaced with amino acids
carrying hydrophobic side chains, the residues that most com-
monly substitute for C764 and C837. We showed that an NL43
envelope lacking gp41 cytoplasmic cysteines and with phenyl-
alanine at position 764 is efficiently assembled on virions and
confers near-wild-type levels of infectivity. This envelope was
excluded from DRM-L but retained its association with
DRM-H.
Construction of NL43 gp41 mutants. C764 and C837 are
usually the only cysteine residues present in the gp41 trans-
membrane and cytoplasmic regions. C764 is highly conserved.
A cysteine is present at position 764 in over 93% of the se-
quences of 291 aligned envelopes in the HIV sequence data-
base (http://hiv-web.lanl.gov). Phenylalanine is the most com-
mon substitute for cysteine at residue 764. Moreover, three
infectious HIV-1 molecular clones which lack cytoplasmic cys-
teines (BORI [F764/Y837], JRCSF [F764/Y837], and DH123
[F764/G837]) each contain phenylalanine at position 764. Only
about 40% of the HIV-1 strains carry a cysteine at position 837,
while 37% have a residue with a bulky hydrophobic side chain
including tyrosine, phenylalanine, and tryptophan. The cyto-
plasmic domain of NL43 gp41 contains only one cysteine
(C764) and has a tyrosine at position 837 (Y837). Thus, only
one amino acid substitution is required to completely eliminate
cysteines from the cytoplasmic region of NL43 gp41. We first
substituted phenylalanine for cysteine at residue 764 to con-
struct an F764/Y837 NL43 envelope. We also introduced ala-
nines at residues 764 and 837, since this residue is frequently
used in mutagenesis studies. Additionally, we constructed an
S764/S837 mutant, since this combination was previously re-
ported to abrogate envelope incorporation onto virions and
infectivity (21). These and other envelope mutants constructed
are shown in Fig. 1B. Mutations were introduced by PCR into
the NL43 envelope sequence contained in the pSVIIIenv ex-
pression vector. The presence of mutations was confirmed by
sequencing.
Mutant NL43 envelopes lacking cytoplasmic cysteines are
expressed and functional. We first sought to evaluate whether
mutant envelopes were expressed in 293T cells. Each
pSVIIIenv construct was cotransfected into 293T cells with a
pNL43env construct. pNL43env expresses all HIV proteins
(except envelope) required for particle formation. pNL43env
also expresses TAT, which is required for efficient envelope
expression from pSVIIIenv. Forty-eight hours after transfec-
tion, 293T cells were permeabilized with methanol-acetone
(1:1) and immunostained with Chessie 8, an anti-gp41 mono-
clonal antibody (MAb) (5). Positively stained envelope-ex-
pressing cells were clearly visible for each mutant envelope
construct (Fig. 2A). We next tested whether each mutated
envelope was expressed on the cell surface. Transfected 293T
cells were removed by treatment with EDTA 48 h after trans-
fection, and envelope expression was tested by flow cytometry
with gp120-specific MAb 902 (5, 19). Figure 2B shows that
293T cells transfected with each mutant envelope were positive
for cell surface expression of gp120. These results indicate that
palmitoylated cysteines in gp41 are not essential for the ex-
pression or cell surface trafficking of the HIV-1 envelope and
confirm previously reported observations for S764/S837 HIV-1
envelope mutants (21, 26).
The ability of HIV-1 gp120 to mediate cell-cell fusion is
frequently used to assess envelope function as well as receptor-
coreceptor utilization. Transfected 293T cells expressing mu-
tant envelopes were tested for their capacity to induce syncytia
in CD4, GHOST/CXCR4 and NP2/CD4/CXCR4 cells. Fig-
ure 2C shows syncytia induced following cocultivation of NP2/
CD4/CXCR4 cells (23) with 293T cells cotransfected with pS-
VIIIenv and pNL43env. Each mutant envelope was
functional for cell-cell fusion and induced levels of syncytia
comparable to those of the NL43 wild-type envelope. Syncytia
induced by each mutant envelope became apparent in the
culture at the same time (between 5 and 6 h) after env 293T
cells and NP2/CD4/CXCR4 were mixed.
Effect of gp41 mutations on infectivity. Each env
pSVIIIenv plasmid was cotransfected with pNL43env into
FIG. 1. The cytoplasmic domain of gp41. (A) LLP-1, LLP-2, and
LLP-3 are putative -helices that are proposed to interact with lipid
bilayers. Palmitate groups covalently attached to C764 and C837 may
insert into the lipid bilayer and anchor these regions to the plasma
membrane. Palmitoylation may target gp41 into lipid rafts (21).
(B) Amino acid substitutions introduced into the gp41 cytoplasmic
domain.
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FIG. 2. Envelope expression and function. (A) 293T cells were cotransfected with pNL43env and pSVIIIenv containing gp41 envelope
mutants (C764/Y837 [CY], F764/Y837 [FY], A764/A837 [AA], and S764/S837 [SS]) and were immunostained for envelope. Cells were fixed and
permeabilized with methanol-acetone (1:1) 48 h after transfection before immunostaining with anti-gp41 MAb Chessie 8 (1). (B) Cell surface
envelope expression. 293T cells (transfected as described for panel A) were stained for surface envelope expression by using anti-gp120 MAb 902
(5, 19) and examined by flow cytometry. (C) Cell-cell fusion induced by NL43 mutant envelopes. 293T cells (transfected as described for panel A)
were cocultivated with NP2/CD4/CXCR4. Cells were fixed and stained with 1% methylene blue–0.25% basic fuchsin in methanol.
FIG. 3. Infectivity conferred by HIV-1 NL43 envelopes lacking gp41 cytoplasmic cysteines. Infectivity was tested with CD4 indicator cell lines
as shown. (A) GHOST parental cells that express endogenous CXCR4; (B) NP2/CD4/CXCR4 cells; (C) GHOST/CXCR4 cells. Cells were fixed
72 h after infection and immunostained for p24. Infectivity titers were then scored as focus-forming units (FFU) per picogram of RT in virus
supernatants as measured by ELISA.
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293T cells. Pseudotype viruses were harvested 48 h posttrans-
fection and measured for reverse transcriptase (RT) activity
with an RT–enzyme-linked immunosorbent assay (ELISA) kit
(Cavidi Tech Inc., Uppsala, Sweden). Pseudotype viruses car-
rying wild-type and mutant envelopes were tested in single-
round infectivity assays with CD4 CCR5 GHOST and NP2/
CD4/CXCR4 cells. Cells were challenged with pseudotype
viruses containing equal amounts of RT activity. Infectivity was
reduced by replacement of C764 with other residues (Fig. 3A).
The replacement of C764/Y837 with S764/S837 resulted in
approximately 90% reduction in infectivity, consistent with
previous reports (21). The infectivity of the A764/A837 mutant
was also reduced; however, this mutant consistently retained
up to 40% infectivity compared to the NL43 wild-type enve-
lope. In contrast, the F764/Y837 mutant envelope retained
over 80% infectivity compared to the wild type and this enve-
lope was therefore nearly fully functional. Figure 3C shows the
infectivity conferred by other envelope mutants lacking cyto-
plasmic cysteines, including F764/A837 and A764/Y837 as well
as C764/A837. These results show a range of infectivities from
40 to 95% of the infectivity measured for the wild-type
envelope.
Effect of gp41 mutations on envelope incorporation onto
virions. We next investigated how the gp41 substitutions af-
fected incorporation of the envelope onto virus particles. 293T
cells were cotransfected with pSVIIIenv containing either
S764/S837, A764/A837, F764/Y837, or C764/Y837 mutant en-
velope together with pNL43env. The envelope-positive
pseudotype viruses were harvested at 48 h, centrifuged at low
speed, and passed through 0.45-m-pore-size syringe filters to
remove cell debris and residual 293T cells. Virus particles were
pelleted at 100,000  g for 2 h at 4°C, and the pellets were
reconstituted in phosphate-buffered saline. The RT activity of
each reconstituted pellet was measured by RT-ELISA, and
equal amounts of RT activity were then resolved by sodium
dodecyl sulfate-polyacrylamide gel electrophoresis; then, the
pellet was blotted and probed for gp160/gp41 with the Chessie
8 MAb and for p24 with 183-H12-5C (25). Figure 4 shows the
level of each NL43 gp41 mutant envelope on virions. As pre-
viously reported (21), the S764/S837 mutant envelope was as-
sembled very inefficiently on virions. The assembly of the
A764/A837 envelope was also reduced compared to that of the
wild-type envelope, while only a modest reduction was ob-
served for F764/Y837. These results show that the replacement
of NL43 gp41 cytoplasmic cysteines consistently reduced the
amount of envelope incorporated onto virions. Substitutions
with amino acids that carried bulky hydrophobic side chains
conferred only a minimal reduction of envelope on virions,
while substitutions with serine residues resulted in a severe
decrease of virion-associated envelope.
FIG. 4. Incorporation of mutant NL43 envelopes onto virus particles. 293T cells were cotransfected with pNL43env and pSVIIIenv containing
gp41 envelope mutants (C764/Y837 [CY], F764/Y837 [FY], A764/A837 [AA], and S764/S837 [SS]). Supernatants harvested 48 h after transfection
were spun at low speed and filtered through a 0.45-m-pore-size syringe filter. The supernatants were then ultracentrifuged at 100,000  g for 2 h
at 4°C to pellet virus particles. The pelleted virions were resuspended and measured for RT activity. Equivalent amounts of RT activity were then
resolved on a sodium dodecyl sulfate–8% polyacrylamide gel electrophoresis gel followed by Western blotting with anti-gp41 Chessie 8 or anti-p24
183-H12-5C as primary antibodies. (A) Western blot analysis of envelope on virions; (B) ratios of envelope to p24 gag concentration evaluated by
densitometry of Western blot bands.
FIG. 5. Association of mutant NL43 envelopes with lipid rafts. 293T cells were cotransfected with pNL43env and pSVIIIenv containing gp41
envelope mutants. Cells were lysed with 0.5% Triton X-100 in TNE buffer on ice. Lysates were homogenized, cleared of nuclei, adjusted to 60%
sucrose, and applied to the bottom of a sucrose gradient (see text). Gradient fractions were Western blotted and probed for envelope and gag with
mouse MAbs. (A) Sucrose gradient fractionation of cold Triton X-100 extracts from 293T cells cotransfected with pNL43env and pSVIIIenv
encoding the NL43 envelope mutants C764/Y837 (CY), F764/Y837 (FY), A764/A837 (AA), and S764/S837 (SS). Note that the NL43 CY envelope
associates with both the DRM-L and the DRM-H fractions. FY is excluded from DRM-L but retains an association with DRM-H. The AA and
SS envelopes are completely excluded from rafts. (B) Sucrose gradient fractionations, as described for panel A except that Triton X-100 extractions
were carried out at 37°C to solubilize lipid rafts. Note that all the gag precursor and envelope detected is present in the fractions representing
soluble membranes and not at densities that correspond to lipid rafts. (C) Sucrose gradient of 293T cold Triton X-100 extracts, blotted and probed
with a rabbit polyclonal antibody to caveolin (molecular mass, 20 to 22 kDa; DRM-L marker) (BD Biosciences Transduction Laboratories Inc.).
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Association of envelope mutants with lipid rafts. Finally, we
tested whether envelope mutants that lacked cysteines in the
cytoplasmic domain were associated with lipid rafts. The pro-
cedures used to analyze lipid rafts were based on those de-
scribed previously by others (7, 16). 293T cells (1.2  106 cells)
were transfected with pNL43env and pSVIIIenv constructs
carrying each envelope mutant. Transfected cells were lysed
with Triton X-100 at a final concentration of 0.5% in TNE (10
mM Tris, 100 mM sodium chloride, 10 mM EGTA [pH 7.5],
protease inhibitor cocktail [Sigma Inc.]) for 30 min. Lysates
were homogenized and centrifuged at low speed to remove
nuclei. Supernatants were adjusted to 60% sucrose in a 1-ml
volume and loaded on top of 250 l of 80% sucrose. The
sucrose gradient was completed by layering 1 ml of 50% su-
crose, 3 ml of 38% sucrose, and 750 l of 10% sucrose on top
of the lysate sample. These steps were carried out with the
sample either on ice or at a temperature below 4°C. Sucrose
gradients were centrifuged for 18 h at 100,000  g (4°C) in an
SW 50.1 Ti rotor. Fourteen fractions were collected, and each
fraction was immunoprecipitated with HIV-1 human serum
(1:1,000). Immunoprecipitated proteins were analyzed by poly-
acrylamide gel electrophoresis followed by Western blotting.
Blots were probed with anti-p55gag/p24gag MAb 183-H12-5C
(6) and anti-gp41 MAb Chessie 8 (1) (Fig. 5A). DRM-L and
DRM-H float at densities of 1.09 to 1.13 and 1.16 to 1.2 g/ml,
respectively. The p55gag precursor was detected throughout the
gradient but was concentrated in both DRM-H and DRM-L,
consistent with previously reported observations (18). The en-
velope precursor gp160 and the processed gp41 were consis-
tently both located in the same fractions. The wild-type C764/
Y837 envelope was detected in fractions with densities
consistent with both DRM-L and DRM-H lipid rafts. In con-
trast, envelopes that lacked gp41 cytoplasmic cysteines were
not associated with DRM-L fractions. However, the F764/
Y837 envelope was detected in fractions with densities consis-
tent with DRM-H, indicating that association with these
heavier rafts was retained.
Envelopes that did not contain gp41 cytoplasmic cysteines or
residues with bulky hydrophobic side chains at positions 764/
837 (A764/A837 and S764/S837) were almost completely ex-
cluded from both DRM-L and DRM-H. Treatment of Triton
X-100 cell lysates at 37°C disrupted the DRM relocating en-
velope and the p55gag precursor into the soluble fraction at the
bottom of the gradient (Fig. 5B). Western blots of cold Triton
X-100 extracts of 293T cells, fractionated on sucrose gradients
(prepared as described for Fig. 5A), indicated that caveolin (a
marker for lipid rafts) was contained almost exclusively in
fractions with densities consistent with DRM-L.
These results show that (i) gp41 cytoplasmic cysteines, which
are targets for palmitoylation, are required for the association
of the envelope with DRM-L; (ii) envelopes that contained
residues with bulky hydrophobic side chains (instead of cys-
teines) retained their association with DRM-H and were effi-
ciently assembled on virions; and (iii) envelopes with C764A/
C837A and C764S/C837S substitutions were excluded from
lipid rafts yet were incorporated onto virions with efficiencies
of up to 40% compared to wild-type envelopes.
Previously, Yang et al. (26) reported that gp41 cytoplasmic
cysteines (C764 and C837) were palmitoylated and that the
replacement of these residues completely abolished palmitoy-
lation. Subsequently, Rousso et al. showed that HIV-1 enve-
lopes carrying double C764S/C837S substitutions lost their as-
sociation with lipid rafts, were inefficiently incorporated onto
budding viruses, and conferred only low levels of infectivity
(21). Nevertheless, several infectious molecular clones of
HIV-1, e.g., JRCSF, lack cysteines in the cytoplasmic domain
of gp41 and yet are apparently fully functional and replication
competent. Since no other gp41 amino acid has been shown to
be a substrate for palmitic acid addition (26), this observation
implied that palmitoylation of gp41 was not essential for en-
velope assembly on virions or infectivity.
Palmitoylation occurs almost exclusively via the covalent
attachment of palmitate groups to cysteine residues via thio-
ester bonds (12, 20). A single exception was recently reported
by Kleuss and Krause (12), who demonstrated that an N-
terminal glycine of the G-protein  subunit Gs was palmitoy-
lated via an amide linkage. The mechanism of glycine palmi-
toylation is unclear, although it is possible that the palmitate
group is transferred from an adjacent palmitoylated cysteine in
Gs (13). Here, we further examined the role of gp41 cyto-
plasmic cysteine residues in envelope assembly. Using HIV-1
NL43, which has only a single gp41 cytoplasmic cysteine at
position 764 (C764), we showed that gp41 cytoplasmic cys-
teines are not required for HIV-1 envelope incorporation onto
virions and infectivity. The replacement of C764 and C837 with
residues carrying bulky hydrophobic side chains may therefore
compensate for the lack of a palmitate group. Here, we showed
that cytoplasmic cysteines which are targets for palmitoylation
are required for the localization of envelope glycoproteins to
light lipid rafts (DRM-L). The replacement of cysteines with
residues that carry bulky hydrophobic side chains resulted in
the retention of the association with heavy lipid rafts
(DRM-H) and conferred near-wild-type levels of envelope as-
sembly on virions. The replacement of cysteines with alanines
or serines eliminated raft association and reduced envelope
incorporation onto virions and the infectivity of virions. Nev-
ertheless, the A764/A837 mutant envelope retained nearly
40% infectivity compared to the wild type, even though this
envelope was excluded from lipid rafts. In summary, our data
show that the presence of cysteine residues in the gp41 cyto-
plasmic domain is not essential for envelope incorporation
onto virions or the infectivity of virions.
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